Table 1 Baseline characteristics

From: The hypoxia marker CAIX is prognostic in the UK phase III VorteX-Biobank cohort: an important resource for translational research in soft tissue sarcoma

 

n =203

%=100

Age

Median 60 years, interquartile range 48–69 years

  

Gender

Male

121

60

Female

82

40

WHO performance status

0–1

163

80

2–3

5

2

Unknown

35

18

Grade

1

14

7

2

39

19

3

150

74

Depth

Superficial

36

18

Deep

166

82

Unknown

1

0

Size

T1 (5 cm)

19

9

T2 (>5 cm)

184

91

Surgical margin

Intralesional

5

2

Marginal

79

39

Wide

119

59

Histologic subtype

Dedifferentiated liposarcoma

5

2

Extraskeletal myxoid chrondrosarcoma

4

2

Leiomyosarcoma

9

4

Malignant peripheral nerve sheath tumour

6

3

Malignant solitary fibrous tumour

4

2

Myxofibrosarcoma

52

26

Myxoid liposarcoma

27

13

Pleomorphic liposarcoma

5

2

Pleomorphic rhabdomyosarcoma

3

1

Synovial sarcoma

6

3

Undifferentiated pleomorphic sarcoma

68

33

Other

13

6

Unknown

1

0

  1. Abbreviation: WHO=World Health Organisation.